Nutranomics Inc

PINK:NNRX USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.63 Million
Market Cap Rank
#37835 Global
#12327 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.02
About

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing Sy… Read more

Nutranomics Inc (NNRX) - Total Assets

Latest total assets as of April 2023: $17.81 Million USD

Based on the latest financial reports, Nutranomics Inc (NNRX) holds total assets worth $17.81 Million USD as of April 2023.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Nutranomics Inc - Total Assets Trend (2008–2022)

This chart illustrates how Nutranomics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Nutranomics Inc - Asset Composition Analysis

Current Asset Composition (July 2022)

Nutranomics Inc's total assets of $17.81 Million consist of 15.2% current assets and 84.8% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 1.9%
Accounts Receivable $1.15 Million 6.4%
Inventory $1.14 Million 6.3%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2008–2022)

This chart illustrates how Nutranomics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Nutranomics Inc's current assets represent 15.2% of total assets in 2022, a decrease from 100.0% in 2008.
  • Cash Position: Cash and equivalents constituted 1.9% of total assets in 2022, down from 100.0% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
  • Asset Diversification: The largest asset category is accounts receivable at 6.4% of total assets.

Nutranomics Inc Competitors by Total Assets

Key competitors of Nutranomics Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Nutranomics Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.03 - 46.11

Lower asset utilization - Nutranomics Inc generates 0.16x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -7602.92% - 11.48%

Negative ROA - Nutranomics Inc is currently not profitable relative to its asset base.

Nutranomics Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.14 0.14 1.62
Quick Ratio 0.07 0.07 1.62
Cash Ratio 0.00 0.00 0.00
Working Capital $-15.62 Million $ -15.37 Million $ 25.49K

Nutranomics Inc - Advanced Valuation Insights

This section examines the relationship between Nutranomics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.02
Asset Growth Rate (YoY) 9.0%
Total Assets $18.03 Million
Market Capitalization $418.94K USD

Valuation Analysis

Below Book Valuation: The market values Nutranomics Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Nutranomics Inc's assets grew by 9.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Nutranomics Inc (2008–2022)

The table below shows the annual total assets of Nutranomics Inc from 2008 to 2022.

Year Total Assets Change
2022-07-31 $18.03 Million +8.99%
2021-07-31 $16.55 Million +62712.56%
2020-07-31 $26.34K -10.53%
2019-07-31 $29.44K -93.44%
2015-07-31 $448.70K -18.44%
2014-07-31 $550.18K +787.54%
2013-07-31 $61.99K -88.32%
2012-07-31 $530.69K +12227.22%
2011-07-31 $4.30K -42.46%
2009-07-31 $7.48K -76.15%
2008-07-31 $31.38K --